Adamis Pharmaceuticals adamantly develops and markets specialty prescription drugs for respiratory ailments, allergies, viral infections, and other medical conditions. Subsidiary Adamis Labs develops and markets allergy, respiratory, and pediatric prescription medicines to physicians in the US. Its products include a pre-filled epinephrine syringe for severe allergic reactions dubbed Epi PFS. Adamis Viral Therapies is developing vaccine technologies for ailments such as influenza and hepatitis. The company is also developing Savvy, a contraceptive gel, and other candidates to potentially treat prostate cancer.